Positive Airway Pressure Devices Market Report Scope & Overview:
The positive airway pressure devices market size was valued at USD 3.21 billion in 2024 and is expected to reach USD 4.89 billion by 2032, growing at a CAGR of 5.42% over the forecast period of 2025-2032.
The global Positive Airway Pressure devices market is expanding since the population suffering over obstructive sleep apnea is increasing due to the lifestyle modifications, including obesity, smoking, alcohol, and sedentary living. These factors lead to airway collapse and poor sleep quality and increase the need for proper treatment. With increased awareness and better diagnostics, plus a trend toward home-based care, more patients are prescribed PAP devices, including CPAP, APAP, and BiPAP to help mitigate symptoms and improve sleep outcomes.
For instance, in February 2025, the U.S. National Sleep Foundation reported an 11% rise in sleep apnea cases linked to obesity, highlighting BMI-driven demand for PAP devices
The U.S. positive airway pressure devices market was valued at USD 1.25 billion in 2024 and is expected to reach USD 1.88 billion by 2032, growing at a CAGR of 5.26% over 2025-2032.
The positive airway pressure devices market in the U.S. is largely driven by its robust healthcare infrastructure, large insurance coverage, and increasing geriatric population. Enabling policies, including Medicare aid access to PAP therapy, home-based care, and telehealth, facilitate the diagnosis and treatment of OSA. The growing need for chronic respiratory care also supplements adoption. These factors compiled lead to the country’s number one positive airway pressure devices market share.
For instance, in March 2025, CMS reported a 9.6% rise in Medicare Advantage enrollment, expanding senior access to PAP devices and reinforcing the U.S. market dominance through policy-driven adoption.Top of Form
Market Dynamics:
Drivers:
-
Rising Awareness and Improved Diagnosis Drive the Positive Airway Pressure Devices Market Growth
Increasing awareness and diagnosis of sleep disorders are some of the key factors driving the positive airway pressure devices market. More public and clinical awareness of conditions, including sleep apnea has led to early identification and intervention. Improved screening devices, public health initiatives, and digital sleep tracking are raising rates of diagnosis and treatment. Rising emphasis on sleep health is significantly increasing its demand globally and drive the global positive airway pressure devices market share across geographies.
For instance, in February 2025, the American Academy of Sleep Medicine reported a 21% rise in sleep apnea screenings in primary care, boosting early diagnoses and PAP device demand.Top of Form
Restraints:
-
Reimbursement Challenges are Restraining the Positive Airway Pressure Devices Market Growth
Reimbursement issues serve as an inhibiting factor for the global positive airway pressure devices market growth. Strict insurance requirements, costly out-of-pocket rental charges, and inadequate coverage of option therapies restrict patient access to PAP. Regional and insurance-based disparities also contribute to inconsistency in the practical approach to diagnosis and treatment. These financial and administrative obstacles result in a large proportion of clinically eligible patients missing the opportunity to receive timely care, which impairs the overall adoption and restrains the positive airway pressure devices market growth.
For instance, in January 2025, the American Sleep Apnea Association reported that 34% of the U.S. patients discontinued PAP therapy within 6 months due to insurance-related barriers and high costs.
Segmentation Analysis:
By Product
Continuous Positive Airway Pressure was the dominant segment in the positive airway pressure devices market analysis, with a 65.70% market share in 2024, as the first-choice therapy for obstructive sleep apnea. High uptake of the monitor is driven by its established effectiveness, ease of use, and widespread clinical acceptance. Robust insurance coverage and home use add to the adoption of CPAP, which adds significantly to the total airway pressure devices market share globally.
Bilevel Positive Airway Pressure is emerging as the fastest-growing segment in the global positive airway pressure devices market, with a CAGR of 6.10%, driven by its ability to manage complicated respiratory disorders as COPD and respiratory failure. The two-pressure setting allows customizing the pressure to each patient for greater comfort and compliance. Growing demand for hospital and critical care use is propelling the adoption, driving a meteoric rise in the positive airway pressure devices market growth in various regions.
By Application
In 2024, the Obstructive Sleep Apnea, controlled positive airway pressure devices market had with 76.64% market share, since it is the most common sleep-related breathing disorder managed using PAP therapy. Mounting obesity, inactive habits, and improved diagnoses lead to higher rates of OSA detection. The high patient population has led to wider adoption of devices, and thus, OSA accounted for the largest positive airway pressure devices market share globally.
COPD is the fastest-growing segment in the global positive airway pressure devices market trend, as a result of expanding international prevalence and the growing adoption of BiPAP for respiratory management. Growing COPD cases, along with increasing exposure to pollution, are leading to demand for non-invasive ventilation. This growing clinical need is driving the global positive airway pressure devices market growth.
By End-user
The Hospitals & Clinics controls the global positive airway pressure devices industry with a significant market share of 72.30%, owing to their importance in early diagnosis, sleep studies, and acute respiratory management. These institutions typically take care of the sickest patients who need BiPAP or CPAP at the inpatient level of care. These players have superior infrastructure and receive reimbursements, which aid them in the swift adoption of high-end positive airway pressure devices market share and ensure dominance in the clinical market.
In the positive airway pressure devices industry, the home care settings segment plays a vital role, registering the fastest growth over the forecast period, driven by the trend to remote monitoring, convenience, and low-cost management of chronic sleep disorders, including OSA. Growing preference for portable and connected PAP devices for long-term home use is increasing the patients’ compliance, thereby responsible to the positive overall airway pressure devices market growth in developed and developing regions.
Regional Analysis:
In 2024, the North American region dominated the positive airway pressure devices industry and accounted for 45.50% of the overall revenue share owing to its state-of-the-art healthcare system, high awareness of sleep diseases, and robust insurance-based modalities. Obstructive sleep apnea is common in the basin due to the high rates of obesity, aging seniors, and a sedentary lifestyle. The availability of diagnostic tools, including home sleep tests and sleep labs, also increases the acceptance of PAP therapy. Moreover, major players, including ResMed and Philips Respironics, are well established in the U.S., ensuring innovative practice and availability, further consolidating the dominance of North America in the PAP devices market.
Europe accounts for the second major share in the global positive airway pressure devices industry on account of an increase in sleep apnea awareness, a growing aged population, and developed public healthcare systems. Stable device uptake is promoted by governmental reimbursement policies and greater acceptance of home-based sleep therapy. Besides this, the availability of prominent manufacturers and increasing clinical attention towards non-invasive respiratory care to lead Europe to a significant position in the global market for positive airway pressure devices.
The Asia Pacific region is projected to grow with the fastest CAGR of 6.04% over the forecast period, fueled by a growing acknowledgment of the issue of sleep disorders, rising obesity, and growing urbanization. With the progression of medical facilities in regions including China, India, and Japan, the early diagnosis and treatment of OSA are increasingly emergent. Furthermore, the demand for at-home sleep testing and portable PAP therapy is increasing as costs decrease and government health agencies promote home testing and therapy as a viable option. It also has the advantage of regional manufacturers providing low-cost solutions. Increasing healthcare expenditure, rise in medical tourism, and increasing prevalence of chronic respiratory diseases are amongst the few positive factors responsible for the demand of medical gases and equipment. Together, these have led to rapid positive airway pressure devices market growth in Asia Pacific and an increased global presence.
The Middle East & Africa have the least share in the positive airway pressure devices market because of low awareness of sleep apnea, underdiagnosis, and limited availability of specialty health care services. Inconsistent reimbursement, economic constraints, and a lack of sleep clinics continue to limit market penetration. Furthermore, the high cost of PAP devices in comparison with the income range also restricts affordability, which in turn dampens greater acceptance, and this is negatively affecting market growth in the region as a whole.
Latin America is a relatively small market for the positive airway pressure devices industry, with growth spurred by increased awareness of sleep apnea and access to healthcare. CPAP and BiPAP use are on the rise in countries including Brazil and Mexico, particularly in urban areas. Nonetheless, economic inequalities, inequality in insurance access, and underdetection still create barriers for PAP therapy implementation on a large scale in the region.
Key Players:
Positive airway pressure device companies include ResMed Inc., Philips Respironics, Fisher & Paykel Healthcare Corporation, Limited, 3B Medical, Inc., DeVilbiss Healthcare LLC, BMC Medical Co., Ltd., Somnetics International, Inc., Vyaire Medical, Inc., Curative Medical, Inc., Löwenstein Medical Technology GmbH + Co. KG, and other players.
Recent Developments:
-
In March 2025, ResMed launched AirSense 11 AutoSet Elite in March 2025, enhancing personalized CPAP therapy with digital coaching and real-time monitoring, improving sleep apnea treatment adherence and clinical outcomes.Top of Form
-
In February 2025, Fisher & Paykel released the NextGen SleepStyle CPAP featuring auto-adjusting humidification, pressure relief, and user-friendly design to boost comfort and adherence in obstructive sleep apnea therapy.Top of Form
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 3.21 billion |
| Market Size by 2032 | USD 4.89 billion |
| CAGR | CAGR of 5.42% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Continuous Positive Airway Pressure, Automatic Positive Airway Pressure, Bilevel Positive Airway Pressure) • By Application (Obstructive Sleep Apnea, Respiratory Failures, COPD) • By End User (Home Care Settings, Hospitals & Clinics, Others )" |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | ResMed Inc., Philips Respironics, Fisher & Paykel Healthcare Corporation, Limited, 3B Medical, Inc., DeVilbiss Healthcare LLC, BMC Medical Co., Ltd., Somnetics International, Inc., Vyaire Medical, Inc., Curative Medical, Inc., Löwenstein Medical Technology GmbH + Co. KG, and other players. |
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Prevalence and Incidence of Sleep Apnea (2023–2025)
5.2 Prescription Trends for PAP Devices, by Region (2023)
5.3 Device Volume and Installed Base, by Region (2020–2032)
5.4 Healthcare Spending on PAP Therapy, by Region (2023)
5.5 PAP Device Software & Connectivity Trends (2023–2025)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Positive Airway Pressure Devices Market Segmentation By Product
7.1 Chapter Overview
7.2 Continuous Positive Airway Pressure
7.2.1 Continuous Positive Airway Pressure Market Trends Analysis (2021-2032)
7.2.2 Continuous Positive Airway Pressure Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Automatic Positive Airway Pressure
7.3.1 Automatic Positive Airway Pressure Market Trends Analysis (2021-2032)
7.3.2 Automatic Positive Airway Pressure Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Bilevel Positive Airway Pressure
7.4.1 Bilevel Positive Airway Pressure Market Trends Analysis (2021-2032)
7.4.2 Bilevel Positive Airway Pressure Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Positive Airway Pressure Devices Market Segmentation By Application
8.1 Chapter Overview
8.2 Obstructive Sleep Apnea
8.2.1 Obstructive Sleep Apnea Market Trend Analysis (2021-2032)
8.2.2 Obstructive Sleep Apnea Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Respiratory Failures
8.3.1 Respiratory Failures Market Trends Analysis (2021-2032)
8.3.2 Respiratory Failures Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 COPD
8.4.1 COPD Market Trends Analysis (2021-2032)
8.4.2 COPD Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Positive Airway Pressure Devices Market Segmentation By End User
9.1 Chapter Overview
9.2 Home Care Settings
9.2.1 Home Care Settings Market Trends Analysis (2021-2032)
9.2.2 Home Care Settings Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Hospitals & Clinics
9.3.1 Hospitals & Clinics Market Trends Analysis (2021-2032)
9.3.2 Hospitals & Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Others
9.4.1 Others Market Trends Analysis (2021-2032)
9.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Positive Airway Pressure Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.2.3 North America Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.2.4 North America Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.5 North America Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.2.6.2 USA Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.6.3 USA Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.2.7.2 Canada Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.7.3 Canada Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.2.8.2 Mexico Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.8.3 Mexico Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3 Europe
10.3.1 Trends Analysis
10.3.2 Europe Positive Airway Pressure Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.3 Europe Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.4 Europe Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.5 Europe Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.6 Germany
10.3.1.6.1 Germany Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.1.6.2 Germany Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.1.6.3 Germany Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.7 France
10.3.7.1 France Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.7.2 France a Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.7.3 France Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.8 UK
10.3.8.1 UK Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.8.2 UK Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.8.3 UK Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.9 Italy
10.3.9.1 Italy Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.9.2 Italy Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.9.3 Italy Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.10 Spain
10.3.10.1 Spain Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.10.2 Spain Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.10.3 Spain Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.12 Poland
10.3.12.1 Poland Positive Airway Pressure Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.12.1 Poland Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.12.3 Poland Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.12.3 Poland Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.13 Turkey
10.3.13.1 Turkey Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.13.2 Turkey Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.13.3 Turkey Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.14 Rest of Europe
10.3.14.1 Rest of Europe Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.14.2 Rest of Europe Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.14.3 Rest of Europe Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4 Asia-Pacific
10.4.1 Trends Analysis
10.4.2 Asia-Pacific Positive Airway Pressure Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.4.3 Asia-Pacific Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.4 Asia-Pacific Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.5 Asia-Pacific Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.6.2 China Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.6.3 China Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.7.2 India Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.7.3 India Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.8.2 Japan Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.8.3 Japan Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.9.2 South Korea Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.9.3 South Korea Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.10 Singapore
10.4.10.1 Singapore Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.10.2 Singapore Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.10.3 Singapore Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.11 Australia
10.4.11.1 Australia Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.11.2 Australia Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.11.3 Australia Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.12 Rest of Asia-Pacific
10.4.12.1 Rest of Asia-Pacific Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.12.2 Rest of Asia-Pacific Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.12.3 Rest of Asia-Pacific Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Trends Analysis
10.5.2 Middle East and Africa East Positive Airway Pressure Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.5.3Middle East and Africa Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.5.4 Middle East and Africa Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.5 Middle East and Africa Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.6 UAE
10.5.6.1 UAE Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.5.6.2 UAE Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.6.3 UAE Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.7 Saudi Arabia
10.5.7.1 Saudi Arabia Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.5.7.2 Saudi Arabia Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.7.3 Saudi Arabia Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.8 Qatar
10.5.8.1 Qatar Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.5.8.2 Qatar Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.8.3 Qatar Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.9 South Africa
10.5.9 1 South Africa Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.5.9 2 South Africa Positive Airway Pressure Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
10.5.9 3 South Africa Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.10 Rest of Middle East & Africa
10.5.10.1 Rest of Middle East & Africa Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.5.10.2 Rest of Middle East & Africa Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.10.3 Rest of Middle East & Africa Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Positive Airway Pressure Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.6.3 Latin America Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.6.4 Latin America Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.5 Latin America Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.6.6.2 Brazil Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.6.3 Brazil Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.6.7.2 Argentina Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.7.3 Argentina Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.8 Rest of Latin America
10.6.8.1 Rest of Latin America Positive Airway Pressure Devices Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.6.8.2 Rest of Latin America Positive Airway Pressure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.8.3 Rest of Latin America Positive Airway Pressure Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
12. Company Profiles
12.1 ResMed Inc.
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 Philips Respironics
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 Fisher & Paykel Healthcare Corporation Limited
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 3B Medical, Inc.
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 DeVilbiss Healthcare LLC
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 BMC Medical Co., Ltd.
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 Somnetics International, Inc.
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 Vyaire Medical, Inc.
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 Curative Medical, Inc.
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 Löwenstein Medical Technology GmbH + Co. KG
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysi
12. Use Cases and Best Practices
13. Conclusion
Key Segments:
By Product
-
Continuous Positive Airway Pressure
-
Automatic Positive Airway Pressure
-
Bilevel Positive Airway Pressure
By Application
-
Obstructive Sleep Apnea
-
Respiratory Failures
-
COPD
By End User
-
-
Home Care Settings
-
Hospitals & Clinics
-
Others (Long-Term Care Facilities, etc.)
-
Request for Segment Customization as per your Business Requirement: https://www.snsinsider.com/sample-request/7513
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Turkey
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
